Oppenheimer Downgrades Simcere Pharmaceutical Group. (SCR) to Perform
Tweet
Share
E-mailGet Alerts SCR Hot Sheet
Price: $35.58 --0%
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Oppenheimer downgraded Simcere Pharmaceutical Group. (NYSE: SCR) from Outperform to Perform.
For more ratings news on Simcere Pharmaceutical Group. click here and for the rating history of Simcere Pharmaceutical Group. click here.
Shares of Simcere Pharmaceutical Group. closed at $9.15 yesterday.
For more ratings news on Simcere Pharmaceutical Group. click here and for the rating history of Simcere Pharmaceutical Group. click here.
Shares of Simcere Pharmaceutical Group. closed at $9.15 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Axis Capital Limited Downgrades Tata Motors Passenger Vehicles (TMPV:IN) to Sell (4)
- Desjardins Downgrades Alithya Group Inc. (ALYA:CN) (ALYA) to Hold
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
